Schedule 13D ownership disclosure

Sucampo Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 864909106

Event date: 2017-06-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-297888
Form type
SC 13D/A
Filer
Sachiko Kuno Foundation, Inc.
CIK
CIK 1693304
Filed
Sep 28, 2017
Reporting period
Jun 12, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub